Pseudohypoparathyroidism (PHP) and related diseases are associated with a series of pathological changes, neurocognitive, and endocrine abnormalities, mainly due to the GNAS mutation on chromosome 20q13.2, which leads to the weakening of receptor‐mediated hormone signal transduction. This evidence concerns the gene GNAS and pseudohypoparathyroidism.